首页> 外文期刊>Acta Neurochirurgica >Evidence-based clinical management and utilization of new technology in European neurosurgery
【24h】

Evidence-based clinical management and utilization of new technology in European neurosurgery

机译:欧洲神经外科循证临床管理和新技术的利用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Evidence-based medicine (EBM) has become one of the pillars of modern patient care. However, neurosurgery has always been an experience-based and technology-driven discipline, and it remains unknown to which extent European neurosurgeons follow high-level evidence-based recommendations. Methods: We conducted a Web-based survey with a 15-item questionnaire about evidence-based clinical management and utilization of new technology among European neurosurgeons. Two different sum scores were calculated from the questions concerning clinical practice; evidence-based treatment score and new technology score. A high evidence-based treatment score means that more clinical conditions (i.e., study questions) were managed in compliance with the available highest levels of evidence from published clinical trials. A high new technology score reflects the use of a high number of modern tools in neurosurgical practice. Results: A total of 239 neurosurgeons from 30 different European countries answered the questionnaire. There were large variations among European neurosurgeons in providing evidence-based care and in utilization of various modern tools. There were significant regional differences in evidence-based treatment scores and modern technology scores with higher scores in northern and western Europe. High-volume institutions were not associated with better evidence-based treatment scores, but had significantly higher new technology scores. There were significantly higher new technology scores at university hospitals and a trend towards higher evidence-based treatment scores compared to other hospitals. Conclusions: Clinical management in neurosurgery does not always comply with the best available evidence and there are large regional differences in clinical management and in utilization of various modern tools. The position of evidence-based medicine in European neurosurgery seems weak and this may be a threat to the quality of care.
机译:背景:循证医学(EBM)已成为现代患者护理的支柱之一。但是,神经外科一直是一门基于经验和技术驱动的学科,目前尚不清楚欧洲神经外科医师在多大程度上遵循基于证据的高级建议。方法:我们进行了一项基于Web的调查,其中包含15个项目的问卷调查,涉及欧洲神经外科医师的循证临床管理和新技术的利用。从有关临床实践的问题中计算出两个不同的总分;循证治疗评分和新技术评分。以证据为基础的高治疗分数意味着要根据已发表的临床试验中可用的最高证据水平来管理更多的临床情况(即研究问题)。高新技术得分反映了神经外科实践中大量现代工具的使用。结果:来自30个不同欧洲国家的239位神经外科医师回答了问卷。在提供循证护理和利用各种现代工具方面,欧洲神经外科医师之间存在很大差异。在北欧和西欧,循证治疗得分和现代技术得分存在显着的地区差异,得分更高。高容量的机构与更好的循证治疗分数无关,但是具有更高的新技术分数。与其他医院相比,大学医院的新技术得分明显更高,并且以证据为基础的治疗得分也有趋势。结论:神经外科的临床管理并不总是符合最佳的现有证据,并且在临床管理和各种现代工具的利用方面存在很大的地区差异。循证医学在欧洲神经外科中的地位似乎很弱,这可能对医疗质量构成威胁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号